Stockreport

IceCure Medical Reports Full Year 2023 Financial Results: Global ProSense® and Disposables Sales Increase 26% as Company Continues Transition to Commercial Phase and Expects to Submit ICE3...

IceCure Medical Ltd. - Ordinary Shares  (ICCM) 
PDF Conference call to be held today at 10:00 am Eastern Time; Focus on U.S. market for ProSense® in breast cancer indicationCAESAREA, Israel, April 3, 2024 /PRNewswire/ -- [Read more]